3308-95-0

Basic information

• Product Name: 1H-Isoindole-1,3(2H)-dione, 2-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-
• CAS NO: 3308-95-0
• Molecular Formula: C20H18FNO4
• Molecular Weight: 355.366
• Mol File: 3308-95-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1H-Isoindole-1,3(2H)-dione, 2-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Isoindole-1,3(2H)-dione, 2-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-(3308-95-0)
• EPA Substance Registry System: 1H-Isoindole-1,3(2H)-dione, 2-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-(3308-95-0)

Safety Data

• Hazardous Substances Data: 3308-95-0(Hazardous Substances Data)

Usage

Molecular structure

A complex compound with a heterocyclic isoindole ring and a dioxolane moiety.

Component groups

Composed of a 4-fluorophenyl group, a 1,3-dioxolane-2-ylpropyl chain, and an isoindole-1,3(2H)-dione core.

Attachment

The 4-fluorophenyl group is linked to the 1,3-dioxolane-2-ylpropyl chain, which is attached to the isoindole-1,3(2H)-dione core.

Potential pharmacological activity

The chemical structure suggests possible activity as a drug candidate or research tool for understanding biological processes.

Further studies needed

Additional research and characterization are required to determine specific properties and potential applications of this compound.

Upstream product

• 3874-54-2 4-(4-fluorophenyl)-4-oxo-n-butyl chloride 
• 1074-82-4 potassium phtalimide 
• 3308-94-9 4-chloro-1-(4-fluorophenyl)-1,1-(ethylenedioxy)butane 

Downstream Products

• 3308-93-8 4-amino-1-(4-fluorophenyl)-1-butanone ethylene ketal 
• 22217-86-3 2-(4-fluorophenyl)-Δ¹-pyrrolidine 

Relevant articles and documents

Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT(1C)-selective antagonist

DOM [i.e., 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane] is a 5- HT(1C/2) serotonin agonist that exerts stimulus control of behavior in animals. In order to determine if the discriminative stimulus effect of DOM is 5-HT(1C)- or 5-HT2-mediated, it would be informative to conduct tests of stimulus antagonism with a 5-HT(1C)- or 5-HT2-selective antagonist. To date, no such agents exist. Although the neuroleptic agent spiperone binds at D2 dopamine receptors and 5-HT(1A) serotonin receptors, (a) it displays about a 1000-fold selectivity for 5-HT2 versus 5-HT(1C) sites and (b) it has been used as a '5-HT2-selective' antagonist. Because spiperone is a behaviorally disruptive agent, it is not suitable for use in drug-discrimination studies. Using the spiperone molecule as a starting point, a limited structure- affinity investigation was conducted in order to identify a suitable antagonist with high affinity and selectivity for 5-HT2 receptors, and yet an antagonist that might lack the disruptive actions of spiperone. Various modifications of the spiperone molecule were examined, but most resulted in decreased 5-HT2 affinity or in loss of selectivity. One compound, 8-[3-(4- fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (26), was shown to bind at 5-HT2 sites with high affinity (K(i) = 2 nM) and >2,000- fold selectivity versus 5-HT(1C) sites. In tests of stimulus antagonism using rats trained to discriminate 1 mg/kg of DOM from saline vehicle, 26 behaved as a potent antagonist (ED50 = 0.003 mg/kg) and lacked the disruptive effects associated with spiperone. As such, (a) it would appear that the DOM stimulus is primarily a 5-HT2-mediated, and not 5-HT(1C)-mediated, phenomenon, and (b) compound 26 may find application in other pharmacologic investigations where spiperone may not be a suitable antagonist.